These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12691828)

  • 1. Tumor M2-pyruvate kinase in the follow-up of inoperable lung cancer patients: a pilot study.
    Schneider J; Neu K; Velcovsky HG; Morr H; Eigenbrodt E
    Cancer Lett; 2003 Apr; 193(1):91-8. PubMed ID: 12691828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases.
    Schneider J; Morr H; Velcovsky HG; Weisse G; Eigenbrodt E
    Cancer Detect Prev; 2000; 24(6):531-5. PubMed ID: 11198266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring.
    Schneider J; Neu K; Grimm H; Velcovsky HG; Weisse G; Eigenbrodt E
    Anticancer Res; 2002; 22(1A):311-8. PubMed ID: 12017309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Philipp M; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Clin Exp Med; 2003 Feb; 2(4):185-91. PubMed ID: 12624710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer.
    Schneider J; Velcovsky HG; Morr H; Katz N; Neu K; Eigenbrodt E
    Anticancer Res; 2000; 20(6D):5053-8. PubMed ID: 11326667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of tumor M2-PK in thyroid carcinoma: a pilot study.
    Bena-Boupda NF; Rezai SS; Klett R; Eigenbrodt E; Bauer R
    Anticancer Res; 2003; 23(6D):5237-40. PubMed ID: 14981996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Tumor M2-Pyruvate Kinase Levels in Different Cancer Types.
    Muñoz-Colmenero A; Fernández-Suárez A; Fatela-Cantillo D; Ocaña-Pérez E; Domínguez-Jiménez JL; Díaz-Iglesias JM
    Anticancer Res; 2015 Jul; 35(7):4271-6. PubMed ID: 26124389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of TU M2-PK tumor marker for lung cancer diagnostics].
    Oremek G; Kukshaĭte R; Sapoutzis N; Ziolkowski P
    Klin Med (Mosk); 2007; 85(7):56-8. PubMed ID: 17882813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer.
    Bandara IA; Baltatzis M; Sanyal S; Siriwardena AK
    World J Surg Oncol; 2018 Mar; 16(1):56. PubMed ID: 29540198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor type M2 pyruvate kinase expression in advanced breast cancer.
    Lüftner D; Mesterharm J; Akrivakis C; Geppert R; Petrides PE; Wernecke KD; Possinger K
    Anticancer Res; 2000; 20(6D):5077-82. PubMed ID: 11326672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor M2 pyruvate kinase--determination in breast cancer patients receiving trastuzumab therapy.
    Hoopmann M; Warm M; Mallmann P; Thomas A; Göhring UJ; Schöndorf T
    Cancer Lett; 2002 Dec; 187(1-2):223-8. PubMed ID: 12359372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.
    Dhar DK; Olde Damink SW; Brindley JH; Godfrey A; Chapman MH; Sandanayake NS; Andreola F; Mazurek S; Hasan T; Malago M; Pereira SP
    Cancer; 2013 Feb; 119(3):575-85. PubMed ID: 22864959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma.
    Ugurel S; Bell N; Sucker A; Zimpfer A; Rittgen W; Schadendorf D
    Int J Cancer; 2005 Dec; 117(5):825-30. PubMed ID: 15957165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of plasma tumor M2-pyruvate kinase in the diagnosis of gastrointestinal cancer].
    Kim CW; Kim JI; Park SH; Han JY; Kim JK; Chung KW; Sun HS
    Korean J Gastroenterol; 2003 Nov; 42(5):387-93. PubMed ID: 14646575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of biological tumor markers CEA, Cyfra-21, NSE, TU M2-PK in diagnosis and treatment of lung cancer].
    Lazarev SM; Massard Zh; Reshetov AV; Nikolaev GV; Volgin GN; Osipov EV; Lomteva EIu; Nokhrin AV; Kakysheva OE
    Vestn Khir Im I I Grek; 2010; 169(1):39-43. PubMed ID: 20387605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumour M2-pyruvate kinase as a biomarker for diagnosis and prognosis of early-stage non-small cell lung cancer.
    Xu C; Liu W; Li L; Wang Y; Yuan Q
    J Cell Mol Med; 2021 Aug; 25(15):7335-7341. PubMed ID: 34255923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer.
    Ervens J; Fuchs H; Niemann VT; Hoffmeister B
    J Craniomaxillofac Surg; 2008 Mar; 36(2):89-94. PubMed ID: 18243718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.